期刊文献+

蛋白酶抑制剂应用研究进展 被引量:1

Application Process of Proteinase Inhibitor
下载PDF
导出
摘要 蛋白酶抑制剂(PI)是广泛存在于生物体内一种重要生命物质,其主要作用包括:保护个体免受病原体或昆虫侵害;调控内生蛋白酶活性及保护储存蛋白等。该文从PI在HIV、肿瘤等疾病治疗、病虫害防治及在食品工业中应用几方面阐述PI当前研究进展,以供相关研究者参考。 Abstract: Proteinase inhibitor (PI) is an important substance related life activities, which is widely distributed in living organisms. The physiological role of these PI has not been established conclusively and is likely to consist of (1) protection from proteolytic enzymes of various pathogens and insects; (2) regulation of the activity of endogenous proteases; (3) contributing to the pool of storage proteins. In this paper, we summarized the application process in therapies of HIV, tumour etc., prevention of plant diseases and insect pests and food industry process.
出处 《粮食与油脂》 2005年第11期3-6,共4页 Cereals & Oils
关键词 蛋白酶抑制剂 HIV 病虫害 proteinase inhibitor HIV plant diseases and insect pests
  • 相关文献

参考文献45

  • 1Mikhail A. Belozersky, Yakov E.Dunaevsky, et al. Complete amino acid sequence of proteinase inhibitor from buckwheat seeds [J].FEBS Letters, 1995, 371: 264-266.
  • 2Piana S, Carloni P. Conformational flexibility of the catalytic as pdyadin HIV - 1 protease: An abinitio study on the free enzyme [J]. Proteins, 2000, 39 (1): 26- 36.
  • 3张石革.蛋白酶抑制剂的应用[J].西部药学,2005,2(1):47-50.
  • 4Ruscon S, Catamancio S.L.S, Citterio P, et al. Susceptibility to PUN - 140690 (tipranavir) of human immunodeficiency virus type isolates derived from patients with multidrug resistance to other proteinase inhibitors [J]. Antimicrob Agents Chemother, 2000, 44(6): 1667.
  • 5Robinson B.S, Riccardi K.A, Gong Y.F, et al. BMS - 232632, a highly potent human immunodeficiency virus protease inhibitor than can be used in combination with other available antiretroviral agents [J]. Antimicrob Agents Chemother, 2000,44 (8): 2093.
  • 6Holmberg S.D, Moorman A.C, Williamson J.M, Proteinase inhibitors and cardiovascular outcomes in patients with HIV - 1 [J].Lancet, 2002,360: 747-748.
  • 7Tabib A, Leroux C, Mornex J.F, et al. Accelerated coronary atherosclerosis and arteriosclerosis in young human immunodeficiency virus positive patients [J]. Coron. Artery. Dis., 2000, 11:41 -46.
  • 8Noor M.A, Lo J.C, Mulligan K, et al. Metabolic effects of indinavir in healthy HIV - seronegative men [J]. AIDS,2001,15:F11-18.
  • 9Mikhail N.Insulin resistance in HIV related lipodystrophy [J]. Curr Hypertens Rep., 2003,5 (2): 117 - 121.
  • 10唐湘宇,杨向东.蛋白酶抑制剂与血脂和冠心病危险性的关系[J].中国动脉硬化杂志,2005,13(1):105-108. 被引量:3

二级参考文献88

共引文献145

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部